AcquisitionOther
Sierra Oncology, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sierra Oncology, Inc. -> target · $55
With this proposed acquisition, we have the opportunity to potentially bring meaningful new benefits to patients and further strengthen our portfolio of specialty medicines. 1 Naymagon L et al.
Open source record (SEC) ↗